Condition: Acute Cerebral Ischemia · Sponsor: Pharmazz, Inc.
This is a prospective, multicenter, randomized, double-blind, parallel, phase IV study designed to evaluate the safety and efficacy of sovateltide (PMZ-1620, IRL-1620) as a potential treatment for cerebral ischemic stroke.
This description comes directly from the study's public registry record.
Dharmesh Shah, Dr. · +91(120)256-9779 · dharmesh.shah@pharmazz.com
Always discuss trial participation with your own doctor first.
| Guntur Medical College and Government General Hospital | Guntur, Andhra Pradesh, India | Recruiting |
| Lalitha Super Specialities Hospital Pvt. Ltd. | Guntur, Andhra Pradesh, India | Recruiting |
| Radiant Superspeciality Hospital | Amravati, Maharashtra, India | Recruiting |
| Government Medical College and attached Hospitals | Kota, Rajasthan, India | Recruiting |
| KG Hospital and Post Graduate Medical Institute | Coimbatore, Tamil Nadu, India | Recruiting |
| Maharani Laxmibai Medical College | Jhānsi, Uttar Pradesh, India | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05955326